维普中文期刊产品整合服务
51篇 您的检索式:作者名="K Lipski"
    题名 作者 年代 出处 被引量
1原发性高血压患者血清和尿液中肿瘤坏死因子浓度与早期器官损害的关系显示文摘高血压被认为是一种低度炎症性疾病。因此,炎症细胞因子浓度可能在高血压患者体内升高,包括肿瘤坏死因子(tumor necrosis factor,TNF)„该研究由年龄18-65岁的参与者96人组成:原发性高血压患者76例和20名健康对照人群。用诊室和动态血压监测(ambulatory blood pressure monitoring,ABPM)测量血压,采集血液进行实验室检查[TNF,TNF受体(TNF receptor 1,TNFR1)],收集24h尿以评估蛋白尿和TNF浓度。陈嘉睿(译) 叶鹏(审校) Puszkarska A Niklas A Giuszek J Lipski D Niklas K 2019中华高血压杂志2019,27,11:2
2Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin - clavulanate 显示文摘Lipsky BA Itani K Norden C 2004Clin Inject Dis2004,38,1:1
3Treating foot infections in diabetic patients: a randomized, muhicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate显示文摘Lipsky B A Itani K Norden C 2010Clinical Infectious Diseases2010,19,11:1
4Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicil- lin-clavulanate显示文摘Lipsky BA Itani K Norden C 2004Clin Infect Dis2004,380,:1
5Association of specifichaplotypes of D2 dopamine receptor gene with vulnerability toheroin dependence in 2 distinct populations显示文摘Xu K Lichterraann D Lipsky RH 2004Arch Gen Psy-chiatry2004,61,6:1
6The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes : development of an evidence - based global consensus 显示文摘BAKKER K APE LQVIST J LIPSKY B A 2016Diabetes Metab Res Rev2016,32,1:1
7Application of rRNA-targeted oligonucleotide probes in biotechnology 显示文摘Lipski A Friedrich Altendorf K 2001Applied Microbiology & Biotechnology2001,56,:1
8Using maximal sterile barriers to prevent central venous catheter related infection:a systematic evidence-based review显示文摘Hu K K Lipsky B A Veenstra D L 2004Am J Infect Control2004,32,3:1
9Endodontic treatment of a maxillary canine with type 3 dens invaginatus and large periradicu- lar lesion : a case report 显示文摘Lichota D Lipski M Woz'niak K 2008J Endod2008,34,6:1
10Impact of tumor-associated symptoms on the prognos-is of patients with renal cell carcinoma:a single-center experience of 683 patients显示文摘Schips L Lipsky K Zigeuner R 2003Urology2003,62,6:1
11Successful Field Operation Though Seal Development and Testing显示文摘Silvaggo J A Lipski M J Van Bramer K G 1987Lubrication Engineering1987,43,6:1
12Culture of the primary cor-neal epithelium as a potential eomponent of test batteries for eye ir-ritancy testing 显示文摘Sladowski D Liberek I Lipski K 2005Toxicol In Vitro2005,19,7:1
13Impact of tumor-associated symptoms on the progncsis of patients with renal cell carcinoma:a single-center experience of 683 patients显示文摘Schips L Lipsky K Zigeuner R 2003Urology2003,62,6:1
14Did the rate of incidental prostate cancer change in the era of PSA testing?A retrospective study of 1127 patients显示文摘Zigeuner R E Lipsky K Riedler I 2003Urology2003,62,:1
15Culture of the primary corneal epithelium as a potential component of test batteries for eye irritancy testing 显示文摘D adowski I Liberek K Lipski 2005Toxicol In Vitro2005,19,7:1
16Culture of the primary corneal epithelium as a potential component of test batteries for eye irritancy testing 显示文摘SLADOWSKI D LIBEREK I LIPSKI K 2005Toxicol In Vitro2005,19,7:1
17Did the rate of Incidental prostate cancer change in the era of PSA testing? A retrospective study of 1 127 patients显示文摘ZIGEUNER R E LIPSKY K RIEDLER I 2003Urology2003,62,3:1
18Selenium level of patients with newly diagnosed prostate cancer compared with control group显示文摘Lipsky K Zigeuner R Zischka M 2004Urology2004,63,:1
19Asymmetric hydrogenation of methyl alpha-benzamido cinnamate in ionic liquid solvent 显示文摘Boyle K L Lipsky E B Kalberg C S 2006Tetrahedron Lett2006,47,:1
20miR-142-3p is involved in CD25+CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant显示文摘Zhou Q Haupt S Prots I Thümmler K Kremmer E Lipsky PE 0,,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费